ANTIBACTERIAL AND ANTI-INFLAMMATORY ACTIVITIES OF NANOSIMPLICIA PHYLLANTUS EMBLICA L. FRUIT IN SUSPENSION FORMULATION

Authors

  • MASFRIA Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia
  • SUMAIYAH Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy. Universitas Sumatera Utara, Medan, Indonesia
  • HAFID SYAHPUTRA Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia https://orcid.org/0000-0001-6628-7727
  • SILVIA Undergraduate Program, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia

DOI:

https://doi.org/10.22159/ijap.2025v17i2.52608

Keywords:

Antibacterial, Anti-inflammatory, Formulation, Nanosimplicia, Phyllanthus emblica L

Abstract

Objective: Phyllanthus emblica L. fruit, rich in phenolic content, has been traditionally used for its medicinal properties, including antibacterial and anti-inflammatory effects. This study aimed to formulate and evaluate the antibacterial and anti-inflammatory activities of nanosimplicia derived from Phyllanthus emblica L. fruit in suspension form. The objectives were to determine the optimal formulation method based on physical stability and bioactivity and assess the resulting suspension's stability and therapeutic efficacy.

Methods: Nanosimplicia were prepared using ionic gelation, with varying concentrations of chitosan and sodium tripolyphosphate. The optimal formulation was selected based on the highest stability and bioactivity performance. The formulation was evaluated for physical stability, pH, organoleptic properties, and bioactivity against Staphylococcus aureus and Escherichia coli. Anti-inflammatory activity was assessed using the protein denaturation inhibition method with Bovine Serum Albumin (BSA).

Results: The optimal suspension formula (F3), consisting of 200 mg/mL nanosimplicia, 0.25% chitosan, and 0.1% sodium tripolyphosphate, exhibited significant antibacterial activity, with inhibition zones of 15.66 mm for Staphylococcus aureus and 15.53 mm for Escherichia coli (p < 0.05). The anti-inflammatory activity showed 29.70% inhibition at 5 mg/L. F3 was chosen as the optimal formulation due to its superior bioactivity and stability over 30 days, maintaining a pH of 5–6 and stable organoleptic properties.

Conclusion: Phyllanthus emblica L. fruit nanosimplicia in suspension form demonstrated potent antibacterial and anti-inflammatory properties, making it a promising candidate for therapeutic applications targeting bacterial infections and inflammation.

Downloads

Download data is not yet available.

References

Prananda AT, Dalimunthe A, Harahap U, Simanjuntak Y, Peronika E, Karosekali NE, Hasibuan PAZ, Syahputra RA, Situmorang PC, Nurkolis F. Phyllanthus emblica: a comprehensive review of its phytochemical composition and pharmacological properties. Vol. 14, Frontiers in Pharmacology. 2023.

Ahmad B, Hafeez N, Rauf A, Bashir S, Linfang H, Rehman M ur, Mubarak MS, Uddin MS, Bawazeer S, Shariati MA, Daglia M, Wan C, Rengasamy KR. Phyllanthus emblica: A comprehensive review of its therapeutic benefits. South African Journal of Botany. 2021;138.

Huang Z, Wu L, Wang W, Zhou Y, Zhang X, Huang Y, Pan X, Wu C. Unraveling the publication trends in inhalable nano-systems. Journal of Nanoparticle Research. 2021;24(1).

Ridwan F, Fadel M. Preparation of avocado leaf simplicia macro/nanoparticles by using high energy ball mill. IOP Conf Ser Mater Sci Eng. 2021;1041(1).

Masfria, Dalimunthe A, Syahputra H, Sumantri IB, Ersa F. Standardization Study of Simplicia Nanoparticle from Phyllanthus emblica L. Fruit. In: AIP Conference Proceedings. American Institute of Physics Inc.; 2023.

Masfria, Sumaiyah, Syahputra H, Witarman M. Formulation and Evaluation of Antibacterial and Anti-Inflammatory Capsules Containing Phyllanthus emblica L. Fruit Nanoparticles. Science and Technology Indonesia. 2023 Oct 1;8(4):607–15.

Masfria, Syahputra H, Wahyuni HS, Zebua NF, Elizabeth, Marcelynn. Analysis of total flavonoid and antioxidant activity of coconut shell liquid smoke (Cocos nucifera L.) as an antibacterial. Pharmacy Education. 2024 Apr 1;24(2):39–45.

Arozal W, Louisa M, Rahmat D, Chendrana P, Sandhiutami NMD. Development, characterization and pharmacokinetic profile of chitosan-sodium tripolyphosphate nanoparticles based drug delivery systems for curcumin. Adv Pharm Bull. 2021;11(1).

Jang JG, Kang JH, Joe KB, Sakthiabirami K, Jang KJ, Jun MJ, Oh GJ, Park C, Park SW. Evaluation of Physical Properties of Zirconia Suspension with Added Silane Coupling Agent for Additive Manufacturing Processes. Materials. 2022;15(4).

Lubis MF, Syahputra H, Astyka R. Antibacterial Activity Ethanolic Extract of Ocimum basilicum L. Leaves in Inhibiting the Growth of Escherichia coli and Pseudomonas aeruginosa. NSMRJ: Nusantara Scientific Medical Research Journal. 2022;1(1).

Chaithanya M, Uma Maheswari T, Rajeshkumar S. Anti-inflammatory and antioxidant activity of lycopene, raspberry, green tea herbal formulation mediated silver nanoparticle. Journal of Indian Academy of Oral Medicine and Radiology. 2021;33(4).

Zafar F, Jahan N, Khalil-Ur-Rahman, Asi M, Zafar WUI. Nanosuspension enhances dissolution rate and oral bioavailability of Terminalia arjuna bark extract in vivo and in vitro. Asian Pac J Trop Biomed. 2020;10(4).

Nirmala AR, Permatasari L, Muliasari H, Deccati RF. Review: analysis of optimal conditions of BSA protein denaturation inhibition method in anti-inflammatory activity testing of various plant leaf extracts. Journal of Agritechnology and Food Processing. 2023;3(2).

Douadi K, Chafaa S, Douadi T, Al-Noaimi M, Kaabi I. Azoimine quinoline derivatives: Synthesis, classical and electrochemical evaluation of antioxidant, anti-inflammatory, antimicrobial activities and the DNA / BSA binding. J Mol Struct. 2020;1217.

Abdulsattar AM, Hossain MA. Antibacterial and antioxidant potential of Tetraena simplex extracts of various polarities. Toxicol Rep. 2020;7.

Gupta A, Badola A. Pharmaceutical Suspension: a Review. Certified Journal │ Gupta et al World Journal of Pharmaceutical Research. 2022;11(3).

Masfria M, Sumaiyah S, Syahputra H, Jenifer J. Anti-inflammatory and anti-aging activity of hydrogel with active ingredient Phyllantus emblica L. fruit nanosimplicia [Internet]. 2024. Available from: www.jmp.ir

Nurul Suci, Masfria, Aminah Dalimunthe, Hafid Syahputra. Characterization, Phytochemical Screening of Phyllanthus emblica L. Fruit Nanoherbal and Determination of the Estrus Cycle of Female Rats. International Journal of Science, Technology & Management. 2023;4(1).

Khubiev OM, Egorov AR, Kirichuk AA, Khrustalev VN, Tskhovrebov AG, Kritchenkov AS. Chitosan-Based Antibacterial Films for Biomedical and Food Applications. Vol. 24, International Journal of Molecular Sciences. 2023.

Varghese M, Balachandran M. Antibacterial efficiency of carbon dots against Gram-positive and Gram-negative bacteria: A review. Vol. 9, Journal of Environmental Chemical Engineering. 2021.

Anees Ahmad S, Sachi Das S, Khatoon A, Tahir Ansari M, Afzal M, Saquib Hasnain M, Kumar Nayak A. Bactericidal activity of silver nanoparticles: A mechanistic review. Vol. 3, Materials Science for Energy Technologies. 2020.

Krishnaveni M, Mirunalini S. Therapeutic potential of phyllanthus emblica (amla): The ayurvedic wonder. J Basic Clin Physiol Pharmacol. 2010;

Ministry of Health of the Republic of Indonesia. Indonesian Pharmacopoeia VI edition. Ministry of Health of the Republic of Indonesia. 2020.

Liu Y, Wu F, Ding Y, Zhu B, Su Y, Zhu X. Preparation and Characterization of Paclitaxel/Chitosan Nanosuspensions for Drug Delivery System and Cytotoxicity Evaluation In Vitro. Advanced Fiber Materials. 2019;1(2).

Shankar SJ, Jaswanth Gowda BH, Akshatha RS, Metikurki B, Rehamathulla M. A review on the role of nanocrystals and nanosuspensions in drug delivery systems. Vol. 12, International Journal of Applied Pharmaceutics. 2020.

Published

27-12-2024

How to Cite

MASFRIA, SUMAIYAH, SYAHPUTRA, H., & SILVIA. (2024). ANTIBACTERIAL AND ANTI-INFLAMMATORY ACTIVITIES OF NANOSIMPLICIA PHYLLANTUS EMBLICA L. FRUIT IN SUSPENSION FORMULATION. International Journal of Applied Pharmaceutics, 17(2). https://doi.org/10.22159/ijap.2025v17i2.52608

Issue

Section

Original Article(s)

Most read articles by the same author(s)